Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8)

Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8)

Abstract Background Results from recent clinical trials on bone marrow mononuclear cell (BM-MNC) transplantation show that this intervention can help reduce the incidence of heart failure (HF) after acute myocardial infarction (AMI). However, no study has evaluated the effect of the transplantation...

Full description

Bibliographic Details
Main Authors: Armin Attar, Ahmad Monabati, Mohammad Montaseri, Massoud Vosough, Seyed Ali Hosseini, Javad Kojouri, Alireza Abdi-Ardekani, Peyman Izadpanah, Negar Azarpira, Gholamreza Pouladfar, Mani Ramzi
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Trials
Subjects:
Regenerative medicine
Cell therapy
Myocardial infarction
Mesenchymal stem cells
Intracoronary injection
Acute myocardial infarction
Online Access:https://doi.org/10.1186/s13063-022-06594-1

Internet

https://doi.org/10.1186/s13063-022-06594-1

Similar Items